Article
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.
Journal of viral hepatitis - 1 Jun 2017
Conti F, Brillanti S, Buonfiglioli F, Vukotic R, Morelli M C, Lalanne C, Massari M, Foschi F G, Bernabucci V, Serio I, Prati G M, Negri E, Badia L, Caraceni P, Muratori P, Vitale G, Porro A, Morotti M, Mazzella G, Andreone P
Abstract excerpt
The availability of direct-acting antiviral agents (DAA) regimens has expanded the pool of patients eligible for treatment. However, data on the virologic response and tolerability of DAAs in elderly patients are lacking. We evaluated the efficacy and safety of DAAs in patients with advanced fibrosis/cirrhosis in real-life practice with the focus on those aged ≥65 years. Between January and December 2015, all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.